戻る
OS Therapies Inc (OSTX) 収入
OSTX 株価推移チャート
OSTX 収入
OS Therapies Inc
$1.41
2.91%
$0.03
終値： Mar 27, 16:00:00 GMT-4
$1.4
0%
$0
アフターマーケット：Mar 27, 20:00:00 GMT-4
主要データ
前終値
$1.37
始値
$1.38
当日レンジ
$1.37 - $1.52
52週レンジ
$1.12 - $2.57
取引高
585.4K
平均取引高
566.1K
配当利回り
--
1株当たり利益(TTM)
-0.82
時価総額
$49.6M
OSTXとは何ですか？
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. The company is headquartered in Rockville, Maryland and currently employs 4 full-time employees. The company went IPO on 2024-08-01. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. Its lead asset, OST-HER2, is an off-the-shelf immunotherapy, which is a type of cancer treatment that helps one’s immune system fight cancer, comprised of a genetically weakened and modified strain of Listeria monocytogenes, a species of bacteria that causes the infection listeriosis, that expresses HER2 peptides. OST-tADC is a tunable ADC with a plug-and-play platform that features tunable pH-sensitive silicone linkers (SiLinkers). Its clinical-stage cancer immunotherapy programs also include OST-AXAL for human papilloma virus (HPV)-associated cancers; OST-503 for non-small cell lung cancer (NSCLC) & glioblastoma; and OST-PSA for prostate cancer.